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Ah&act 
Conditioned media of human glial cell lines induced alkaline phosphatase activity in cultured calf artery endothelial cells. The maximal alkaline 
phosphatase activity in the culture was comparable to the level in isolated brain capillary endothelial cells. An induction factor in the conditioned 
media was purified and identified as interleukind from its amino-terminal sequence, molecular weight, amino acid composition and immunoreactivity. 
Recombinant interleukin-6 had similar induction activity. Our findings raise the possibility that interleukin-6 induces and modulates alkaline 
phosphatase activity in endothelial cells during normal development of the blood-brain barrier and under certain pathological conditions. 
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1. Introduction 
Brain capillary endothelial cells, site of the blood- 
brain barrier (BBB), are specifically differentiated; they 
are impermeable to most blood-borne molecules and ex- 
press many kinds of transporters and enzymes for uptake 
of nutrient molecules [l-3]. In the brain, alkaline phos- 
phatase (ALP; EC 3.1.3.1) activity is markedly high in 
endothelial cells of BBB-type microvessels, and negative 
or low in those of non-BBB type vessels [1,2,4,5]. The 
ALP levels parallel the maturation of BBB in the newly- 
formed capillary endothelial cells during normal devel- 
opment in the brain [2,4,6] and during repair processes 
after brain injury and inflammation [7]. Thus, ALP has 
been accepted as a marker enzyme for the BBB [l-4]. 
Stewart and Wiley [8] showed that abdominal vessel 
vascularizing grafted neural tissue became impermeable 
to circulating dye and expressed high ALP activity. They 
suggested that BBB properties, i.e. restricted permeabil- 
ity and expression of many BBB marker proteins, are not 
natural endowments of the endothelium of the BBB, but 
can be induced, even in endothelial cells of peripheral 
tissue origin. The nervous cells surrounding the brain 
capillary endothelial cells, i.e. astrocytes, pericytes, and/ 
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or neurons, are likely to be responsible for the induction 
of differentiated BBB endothelial cells [l-3]. Conflicting 
studies have been reported for the induction mechanism, 
whether cell-to-cell contact or soluble factors are needed 
[l-3,9-16]. No molecule derived from these cells has yet 
been identified which induces any BBB markers in endo- 
thelial cells. 
In this study, we focused on conditioned media (CM) 
of various human glial cell lines and examined them for 
their ability to induce ALP activity in cultured endothe- 
lial cells. Our preliminary studies using a rapid, sensitive 
screening method for detecting ALP activity in cultured 
cells [ 171 showed that ALP activity was elevated in calf 
pulmonary artery endothelial (CPAE) cells cultured with 
CMs of human glial cell lines; especially high activity was 
noted for CM of human glioma Hs683 cells. A factor 
that elevated the ALP activity was purified from Hs683 
CM, and identified as interleukin-6 (IL-6). Possible bio- 
logical implications of our findings are discussed. 
2. Experimental 
2. I. Recombinant IL-6 and antibodies 
Recombinant human IL-6 (rIL-6), purified from CM of Chinese 
hamster ovary cells, and mouse monoclonal antibody to this rIL-6 
preparation were from Genzyme Corp. (MA, USA). The rIL-6 was 
used after its actual content in the material was determined by an 
immunoassay as stated below (section 2.9). Mouse anti-IL-6 monoclo- 
nal antibody (B-ES) was from Boehringer-Mannheim Biochemic (IN, 
USA). 
2.2. Cell culture 
Human cell lines, Hs683 (glioma, ATCC No. HTB 138), H4 (neuro- 
glioma, ATCC No. HTB 148), A172 (glioblastoma, ATCC No. CRL 
1620), U-373 MG (glioblastoma, ATCC No. HTB 17), T98G (glioblas- 
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toma, ATCC No. CRL 1690), IMR-32 (neurobl~toma ATCC No. 
CCLl27), KD (lip fibroblast, ATCC No. CRL 1295), and KHOS240S 
(osteosarcoma, ATCC No. CRL 1545), were cultured in collagen- 
coated dishes (Corning 100 mm in diameter) in DMEM (Dulbecco’s 
modified Eagle medium containing 10% fetal calf serum (FCS)). CPAE 
(calf pulmonarv arterv endothelial cells) (ATCC No. CCL209) were 
cultured in EMEM (Eagle’s minimum ‘essential medium ~ont’aining 
20% FCS). On induction experiments, CPAE cells were cultured for 4 
days or longer with a I : 1 mixture of the EMEM and the sample medium 
(CM, the DMEM or chromatography fraction diluted with the 
DMEM). HUVEC-C (umbilical cord endothelial cells ATCC No. CRL 
1730) were cultured in collagen-coated ishes in 199 media with 20% 
FCS supplemented with nutrients as described before [IS]. PASMC 
(human pulmonary aortic smooth muscle cells, Sanko Junyaku, Osaka, 
Japan) were cultured according lo the supplier’s manual. 
2.3. Preparation of CM 
Hs683 cells were seeded in collagen-coated ishes (lo6 cells/dish in 
10 ml of the DMEM). Four days later, the medium of confluent culture 
was replaced with a fresh one and 48 h later, the CM was harvested and 
filtrated with a sterile 0.2pm filter and stored frozen at -20°C until use. 
In CMs of other cell lines, the media of confluent culture were replaced 
with 10 ml/dish of fresh DMEM and 48-h CMs were collected. 
2.4. ALP assay 
ALP activity in the cultured CPAE cells was determined by methods 
described previously 1181. Briefly, in the ‘DOC extraction method’, 
cultured cells in the collagen-coated ishes were extracted with cold 
aqueous 1% Na-deoxycholate (DOC) solution, then aliquots of the 
extracts were incubated with an aqueous~-nitrophenylphosphate solu- 
tion. Incubation was stopped with 0.01 N NaOH. ALP activity were 
determined by measurement of absorbance at 405 nm and referred to 
as international units (IU) [Is]. In the ‘direct in situ assay’, CPAE cells 
were seeded in a 96-well collagen-coated plate at a cell density of 4 x IO4 
cells/well in 100 ~1 of the EMEM together with 100 ~1 of the sample 
and cultured for 4 days. Cells were drained for the media and washed 
with 0.9% saline, then incubated with 25 @/well of the p-nitrophenyl- 
phosphate solution for 30 min. Incubation was stopped with 0.01 N 
NaOH, and absorbance at 405 nm was measured with a 96-well mul- 
tiphotometer. The ALP-inducing activity in the lOO@ sample that gave 
1 OD at 405 nm in the direct in situ assay was defined as 1 alkaline 
phosphatase induction unit (AIU). The activity was corrected for the 
basal value obtained with the control medium culture. 
2.5. Hoffow-fiber culture and preparation of serwn-free CM 
Hs683 cells (3 x IO* cells) were inoculated into a hollow fiber culture 
system (Cell-Pharm bioreactor system, Unisyn Fibertec Corp., CA, 
USA) using three BR 130 bioreactors with a 10 kDa moiecular weight 
cut-off. Bioreactors were maintained at 37°C and perfused with 2 liters 
of WRC935 medium (Grace & Co., MA, USA) with 10% FCS. Every 
day, the media in the extra-capillary space (about 20 ml in total) and 
in the reservoir were replaced with new ones. As the continual serum- 
free culture caused marked decrease in the yield of the ALP-inducing 
activity, the media in the extra-capillary space were replaced with 
serum-free or serum-containing WRC935 media alternately every day. 
Serum-free CMs (150 ml) obtained as a IOO-fold concentrated solution 
from 18- to SO-day culture were frozen at -20°C until use. 
2.6. Pur~~~ation 
CM (136 ml) from hollow fiber culture was dialyzed against cold 3.3 
mM phosphate buffer pH 7.75 with 1 mM EDTA, aprotinin (2 mgll), 
chymostatin (2 m&ml), and leupeptin (0.5 mg/I). The material was 
applied to an anion-exchange filter (DEAE-Memsep 1010, Millipore 
Corp., MA, USA) equilibrated with the above dialysis buffer at 4°C. 
The fractions that passed through were concentrated 20-fold by spin 
dialysis with Centriprep concentrators (Grace & Co.) and equilibrated 
in 20 mM phosphate buffer pH 6.0 by gel filtration (PDIO column, 
Pharmacia LKB Biotechnology, Uppsala). The material was applied to 
a cation-exchange HPLC column (TSK-Gel SP-5PW 7.5 x 7.5 mm; 
Tosoh, Tokyo) equilibrated with 20 mM phosphate buffer, pH 6.0, and 
eluted with a linear gradient of 0 to 0.25 M NaCl. Fractions of I ml 
were collected and 2 ~1 aliquots were assayed for ALP-inducing activity, 
and the active fractions were applied to a reversed-phase HPLC column 
(Cosmosil C4,4.6 x 250 mm; Nacalai Tesque, Kyoto), and eluted with 
0.1% triguoroacetic acid with a linear gradient of 20-50% acetonitrile. 
Fractions of 0.5 ml were evaporated to dryness by N, gas flashing, and 
redissolved in TPBS (0.15 M phosphate buffered saline plus 0.005% 
Tween 20). One-$ aliquots were assayed and active fractions were 
applied to a HPLC-gel filtration column (TSK-Gel G3000SW, 
7.5 x 600 mm; Tosoh, Tokyo) and eluted with TPBS and fractionated 
in 0.25 ml. Active fractions were collected and subjected to protein 
analyses. 
2.7. Affinity chromatography 
Anti-IL-6 antibody column was prepared from N-hydroxysuccin- 
imide-activated Sepharose (HiTrap, Pharmacia) according to the man- 
ufacturer’s manual using anti-IL-6 monoclonal antibodies (Genzyme). 
CM from the hollow-fiber culture (25 ml in 10% FCS) was applied, and 
adsorbed material was eluted with 0.1 M glycine, HCI buffer, pH 2.6. 
The eluted material (about 50 pug) was neutralized, and a portion was 
applied to the HPLC-gel filtration column. 
2.8. Protein analyses 
Protein concentrations were measured with a protein assay reagent 
(BCA kit, Pierce, IL, USA). The purified protein was analyzed by 
SDS-PAGE in 20% polyacrylamide gel using a PhastSystem (Pharma- 
cia). Amino acid analysis of the purified protein was done with an 
automatic analyzer (Hitachi Model L8500, Hitachi) after dried purified 
protein (35 pmol) was mixed with SO ,& of 4 M methansulfonic acid, 
and hydrolyzed at 110°C for 24 h under reduced oressure. The amino 
terminal sequence of the purified protein (200 pmol) was determined 
with a liquid-phase automatic amino acid sequencer (Applied Biosys- 
terns Model 477A, CA, USA). 
2.9. Enzyme-linked immunosorbent assay (ELISA) 
IL-6 concentration was determined by a sandwich enzyme immu- 
noassay in 96-well microtiter plates (Predicta Interleukin-6 kit, Gen- 
zyme Corp.). 
3. Results 
The specific activity of ALP in CPAE cells cultured 
with the Hs683 CM increased with the number of days 
of culture (Fig. 1). The ALP activity began to increase 
markedly after confluency of the cells at 4-6 days in 
culture. The ALP level in CPAE cells cultured without 
CM was lowest at day 4 to 5, reflecting their basal un- 
stimulated levels. The specific activity of ALP rose in 
14-day-cultured CPAE cells to about 1 ,OOO-times higher 
than these basal levels, and was comparable to the level 
in isolated brain capillary endothelial cells [ 181. The ALP 
activity was elevated even after 1 day of culture of the 
CPAE cells with the CM, and the addition of non-cyto- 
toxic levels of actinomycin D (30 ngfml) and cyclo- 
heximide (4 PM) to the culture suppressed 84% and 
100% of this elevation, respectively, suggesting the in- 
volvement of ALP protein synthesis in the increase in the 
ALP activity. The factor that induced the ALP activity 
did not bind to heparin and was heat-labile; this factor 
was stabie on treatment at 56°C for 30 min, while its 
activity was reduced to 15% of the original on treatment 
at 70°C for 30 min. The apparent molecular weight on 
gel filtration of the ALP-inducing factor in the serum- 
free CM ranged between 20 kDa and 40 kDa with a peak 
of about 21 kDa. 
The ALP-inducing factor was purified from serum- 
free culture in a hollow fiber culture process by four steps 
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Fig. 1. ALP activity in cultured CPAE cells induced by CM of Hs683 
glioma cells. (A) Growth of CPAE cells cultured with (0) or without 
(0) 50% CM of Hs683 cells. Abscissa: days in culture. (B) Specific 
activity of ALP in CPAE cells cultured with (m) or without (0) 50% CM 
of Hs683 cells. ALP activity in the DOC extract was determined as 
described in section 2. Mean f S.E.M. of 4 assays. 
of chromatography (Table 1). Final gel filtration on 
HPLC showed a single peak with a molecular weight of 
21 kDa with ALP-inducing activity. The SDS-PAGE 
analysis of the purified protein showed a single band 
with an apparent molecular weight of 24 kDa (Fig. 2). 
The amino acid sequence of the amino terminus of the 
purified protein was VPPGEDSKDVAAPXXQPL (one 
letter presentation of amino acids, X is unidentified). 
IO1 
Apart from this main sequence, a minor sequence, 
GEDSKDVAAP was also detected; the yield was 14% 
of the total purified protein. Homology search of these 
amino terminal sequences howed that they were both 
identical to the partial sequence of human IL-6 deduced 
from the cDNA sequence [19]. The amino acid composi- 
tion of the purified protein substantially agreed with that 
of human IL-6 (Table 2) [19]. This purified protein re- 
acted with two commercially available monoclonal anti- 
bodies to human IL-6. The IL-6 content estimated by 
ELISA using a monoclonal anti-IL-6 antibody and the 
ALP-inducing activity were almost parallel at each step 
of purification (Table 1). Also, IL-6 in the CM was puri- 
fied more easily by two-step procedures: affinity chro- 
matography and gel filtration (for details, see section 2). 
Thus, an induction factor in the CM was identified as 
IL-6 by biochemical analyses of the purified protein, i.e., 
molecular weight (24 kDa by SDS-PAGE, and 21 kDa 
by gel filtration) [20], amino-terminal sequence, amino 
acid composition, and immunoreactivity to anti-IL-6 
antibodies of the purified protein. Moreover, a recombi- 
nant preparation of IL-6 (rIL-6) had similar ALP-induc- 
ing activity in CPAE cells; it was potent at rig/ml concen- 
trations (Fig. 3). IL-6 content and the ALP-inducing 
activity of CMs of various human glial cell lines and 
other non-glial cell lines (see section 2.2) were deter- 
mined. All glial cell lines examined had the ALP-induc- 
ing activity (data not shown). The CM of Hs683 glioma 
cells had the highest content of IL-6 (75 r&ml) together 
with the highest ALP-inducing activity (192 AIU/ml) 
among the cell lines examined. 
4. Discussion 
Astroglia and microglia produce a large amount of 
IL-6 on brain injury and inflammation [20-221. IL-6 is 
presumed to aid survival and differentiation of neurons 
and regeneration of vessels [20]. Capillary endothelial 
cells newly formed in the injured area first show no or 
weak ALP activity and higher permeability [7]. After two 
weeks, these immature endothelial cells grow into the 
mature type with concomitant appearance of high ALP 
Table 1 
Purification of ALP-inducing activity in Hs683 CM from hollow-fiber culture 
Purification step Protein Activity Specific activity Purification Yield* IL-6** Yield*** 
(mg) (AIU) (AIU/mg) (-fold) (%) olg) (%) 
Medium” 89.92 847552 9426 1 490 
DEAE 44.85 858000 19130 2 101 366 75 
SP 1.20 196333 16361 I 17 23 82 17 
c4 0.10 20865 208650 22 2 ND ND 
G3000SW 0.02 15142 757100 80 2 11 2 
Serum-free CM (I 36 ml) from hollow-fiber culture. *Yield of ALP-inducing activity. **IL-6 content estimated by ELISA. ***Yield of immunoreac- 
tive IL-6. ND. not determined. 
102 
24 kD 
Fig. 2. SDS-PAGE analysis of the protein purified by four-step chro- 
matography. The purified protein, which was electrophoresed under a 
reduced condition in 20% polyacrylamide gel, showed single band with 
an apparent molecular weight of 24 kDa (right lane). The chromatogra- 
phy is summarized in Table 1. 
activity [7]. IL-6 secreted by activated astrocytes may 
induce ALP activity in the endothelial cells under certain 
pathological conditions such as infarct, injury, and in- 
flammation. 
Glucocorticoid, an anti-inflammatory mediator, in- 
duces ALP activity in cultured murine endothelial cells, 
and IL-l suppresses this induction [23]. Taken together 
with our findings, local concentrations of IL-l, IL-6 and 
glucocorticoid may modulate the level of ALP activity 
detected in endothelial cells in peripheral tissues [24] as 
well as in the brain. 
Primary-cultured astrocytes and cultured cell lines of 
glioma and glioblastoma have been shown to secrete 
IL-6 [20,25,26]. CM from primary-cultured astrocytes is 
known to induce development of tight junctions of BBB 
type in cultured CPAE cells [10,14]. CMs of C6 rat gli- 
oma and human astrocytoma cells caused suppression of 
the permeability of cultured brain microvascular endo- 
thelial cells [ 13,151. IL-6 seems unlikely to be responsible 
Concentration of IL-6 (ng /ml) 
Fig. 3. ALP-inducing activity of the purified protein (0) and rIL-6 (0) 
for CPAE cells. CPAE cells cultured in a 96-well plate for 5 days with 
the purified protein or rIL-6 were assayed for ALP activity by direct 
in situ assay. The abscissa indicates the final concentrations of IL-6 in 
the culture, which were determined by ELBA. The purified protein and 
rIL-6 showed similar potency at @ml concentrations. 
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for these inductions, because it rather increases permea- 
bility in cultured carotid endothelial cells [27]. Other 
molecules, e.g. catecholamine [131, or glia-derived uni- 
dentified factors [9,12,16] might have a stronger influ- 
ence on the endothelial permeability than IL-6. 
Minute amounts of IL-6 message are expressed consti- 
tutively in the brain even under normal conditions 
[28,29]. The levels of IL-6 message in the brain are high- 
est at postnatal age 20 days [29]. ALP activity in the 
brain, which is mostly derived from microvascular endo- 
thelial cells, is also highest on similar postnatal days 
[6,30]. This means that concomitant peaks of IL-6 mes- 
sage and ALP activity occur in the brain during onto- 
genesis. Our present findings, together with these obser- 
vations, raise the possibility that minute amounts of IL-6 
secreted by astrocytes induce and maintain ALP activity 
in the microvessels and are responsible for late phase 
maturation or terminal differentiation of the BBB endo- 
thelial cells [2,6]. 
IL-6 signals the terminal differentiation of B cells [20], 
resulting in high ALP activity in plasma cells [31]. Our 
present findings on the endothelial cells suggest a closer 
relationship between IL-6 signaling and ALP induction. 
This view is now supported by sequence analysis on the 
liver/bone/kidney-type ALP gene [32], which both 
plasma cells and endothelial cells express [31,33]. The 
NF-IL6-binding sequence (TGGAGACAAA), an IL-6 
responsive lement, which is a motif sequence found on 
many genes regulated by IL-6 [34], was present upstream 
(-592 to -583) of the ALP gene. 
Table 2 
Amino acid composition of the purified protein 
Amino Composition Theoretical 
acid nmol (Lys = 14) value (IL-6) 
Ala 0.463 13.4 13 
Arg 0.279 8.1 9 
Asx 0.666 19.3 18 
Glx 0.843 24.4 30 
Gly 0.231 6.7 5 
His 0.071 2.1 2 
Ile 0.26 7.5 9 
Leu 0.693 20.1 23 
Lys 0.484 14 14 
Met 0.188 5.4 5 
Phe 0.224 6.5 7 
Pro 0.158 4.6 7 
Ser 0.612 17.7 15 
Thr 0.421 12.2 12 
Trp ND ND I 
Tyr 0.05 1.5 3 
Val 0.099 2.9 6 
ll2Cys 0.11 3.2 4 
Total 5.852 169 183 
18902* 20835* 
*Molecular weight. ND, not detected. 
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Our present findings provide a basis for understanding 
endothelial cell-astrocyte interaction and the involve- 
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